HOME >> MEDICINE >> NEWS
New data support the efficacy and safety of the novel oral anticoagulant Exanta

(Mlndal, Sweden, 10 July 2001) The presentation of a wide range of data at the 18th International Society on Thrombosis and Haemostasis meeting (ISTH) in Paris this week, provided new evidence to support the efficacy and safety of Exanta, which is set to be the first new oral anticoagulant since warfarin was introduced over 50 years ago.

Exanta, an oral direct thrombin inhibitor, is currently under investigation in an extensive phase III clinical trials programme in a number of key therapeutic areas. The programme, which involves more than 15,000 patients in 30 countries, includes European and US phase III studies in the prevention of blood clot formation in the leg veins of patients undergoing orthopaedic surgery, presented at the ISTH. These blood clots in leg veins, or deep vein thrombosis (DVT), can dislodge and travel to the lung causing pulmonary embolism (PE). DVT and PE together are known as venous thromboembolism (VTE).

Dr Ian Watts, Global Product Director, said: "Over 20 abstracts were selected for oral and poster presentation at the ISTH meeting, including the phase III results from US and European trials of VTE prophylaxis in orthopaedic surgery. These data show that Exanta has efficacy and tolerability at least comparable to that of warfarin or a low molecular weight heparin compound, the standard anticoagulants in the US and Europe respectively."

The European phase III trial, one of the largest ever trials of VTE prophylaxis in orthopaedic surgery, included 2788 patients undergoing total hip or total knee replacement surgery, in centres across Europe. The study, which compared the efficacy and safety of Exanta to the low molecular weight heparin, enoxaparin showed it to be effective and well tolerated for VTE prevention, with efficacy comparable to that of enoxaparin. The earlier phase II trial also showed Exanta to be comparable to another low molecular weight heparin, dalteparin.

The US phase III trial,
'"/>

Contact: Rina Amin
rina.amin@ketchum.com
44-20-7611-3513
Ketchum
10-Jul-2001


Page: 1 2 3

Related medicine news :

1. Americans support most uses of reproductive genetic testing, report on US attitudes reveals
2. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
3. Emergency department study supports giving dehydrated children fluids by mouth
4. Early supported discharge services can reduce long term dependency for stroke patients
5. Care of rural stroke patients improves with telephone support
6. Review supports link between HRT and stroke
7. Chamomile tea: New evidence supports health benefits
8. Psychological support helps adolescents with chronic fatigue syndrome
9. Social supports lessen effects of maltreatment on children vulnerable to depression
10. Immigration, lack of partner support are postpartum
11. Study supports the use of mechanical assistance

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2020)... ... ... The secret of surviving a pandemic with one’s sanity intact does not lie in ... first product to disappear off the shelves when the COVID-19 crisis began. The idea ... to venture out, the longer you can “survive”. However, does all this doomsday-like preparation ...
(Date:6/25/2020)... ... 25, 2020 , ... Denials Management, Inc. has just published The Health Insurance ... appeals for denials of mental health and substance use disorder (MH/SUD) treatment services. It ... rights and explain the steps in the appeals process. Complimentary copies of the ...
(Date:6/24/2020)... ... June 24, 2020 , ... SPH Analytics ... Wexford Physician Hospital Organization (PHO) has successfully deployed SPH’s Population Care™ all-payer population ... of value-based care. Use of Population Care is benefitting more than 77,000 patients ...
(Date:6/23/2020)... ... June 23, 2020 , ... Oak Street Health, a network of primary ... for nationwide expansion in 2020 with the company’s first centers in New York and ... in Brooklyn, N.Y., and a new center in Jackson, Miss. , “The planned ...
(Date:6/23/2020)... ... June 22, 2020 , ... In its latest report on ... for the market for tests tied to therapeutic selection or effectiveness. To get ... as well as pharmaceutical companies serving them to determine recent market trends. The ...
Breaking Medicine News(10 mins):
(Date:6/19/2020)... ... June 19, 2020 , ... With the success of ... Warrior Gym at in Queen Creek. Since the foundation of the Conquer Ninja Gyms ... essence, all of the gym locations still share the vision of Jake Marshman, who ...
(Date:6/19/2020)... ... June 19, 2020 , ... ... This campaign showcases the innovative medical research achieved through clinical trials and ... disease treatment. This public awareness campaign aims to foster dialogue among research ...
(Date:6/19/2020)... Okla. (PRWEB) , ... June 19, 2020 , ... ... technology provider, and American Healthcare Staffing Association (AHSA), a pioneer and leader in ... the largest nonprofit Catholic health systems in the United States. AHTG and AHSA ...
Breaking Medicine Technology:
Cached News: